Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation

作者: TOSHIKI MAWATARI , ITASU NINOMIYA , MASAFUMI INOKUCHI , SHINICHI HARADA , HIRONORI HAYASHI

DOI: 10.3892/IJO.2015.3213

关键词: AcetylationSKBR3CellCell growthCell cycleBiologyCancerCell cycle checkpointHistone deacetylaseCancer research

摘要: Breast cancer encompasses a heterogeneous group of diseases at the molecular level. It is known that chemosensitivity breast depends on its subtype. We investigated growth inhibitory effect valproic acid (VPA), histone deacetylase (HDAC) inhibitor, and mechanism this inhibition four cell lines with different subtypes. The VPA in was investigated. alteration levels p21 WAF1, cleaved caspase-3, acetylated Heat shock protein (Hsp) 90, Hsp70, α-tubulin by examined VPA-sensitive, human epidermal receptor 2 (HER2)-overexpressing SKBR3 cells. dependent dose exposure time VPA. HER2-overexpressing line inhibited to much greater degree than other studied. In line, upregulated expression WAF1 caspase-3 early phase. markedly increased Hsp70 acetylation time-dependent manner but did not increase Hsp90 acetylation. Our data demonstrated proliferation induced cycle arrest apoptosis This anti-proliferation might be direct function as an HDAC inhibitor. propose alternative whereby disrupts leads downregulation client proteins, including HER2 indirect VPA, sense non-histone proteins are acetylated.

参考文章(40)
Jing-Yuan Fang, Effects of histone acetylation and DNA methylation on p21WAF1regulation World Journal of Gastroenterology. ,vol. 8, pp. 400- 405 ,(2002) , 10.3748/WJG.V8.I3.400
Christopher C. Benz, Fan Xu, Chloe Marden, Liana Kirk, Gary K. Scott, Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. Molecular Cancer Therapeutics. ,vol. 1, pp. 385- 392 ,(2002)
Lianne Fuino, Peter Atadja, Purva Bali, Hong Gang Wang, Fei Guo, Sylvie Wittmann, Hirohito Yamaguchi, Sreenivasa Donapaty, Kapil Bhalla, Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B Molecular Cancer Therapeutics. ,vol. 2, pp. 971- 984 ,(2003)
Ying Wang, Sheng-Yu Wang, Xu-Hui Zhang, Ming Zhao, Chun-Mei Hou, Yuan-Ji Xu, Zhi-Yan Du, Xiao-Dan Yu, FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70. Biochemical and Biophysical Research Communications. ,vol. 356, pp. 998- 1003 ,(2007) , 10.1016/J.BBRC.2007.03.076
Jessica E. Bolden, Melissa J. Peart, Ricky W. Johnstone, Anticancer activities of histone deacetylase inhibitors Nature Reviews Drug Discovery. ,vol. 5, pp. 769- 784 ,(2006) , 10.1038/NRD2133
B. Gilquin, S. H. Kwon, C. Garrido, T.-P. Yao, C. Vourc'h, P. Matthias, S. Khochbin, C. Boyault, Y. Zhang, S. Fritah, C. Caron, HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes & Development. ,vol. 21, pp. 2172- 2181 ,(2007) , 10.1101/GAD.436407
James R. Davie, Mariko Moniwa, Control of chromatin remodeling. Critical Reviews in Eukaryotic Gene Expression. ,vol. 10, pp. 303- ,(2000) , 10.1615/CRITREVEUKARGENEEXPR.V10.I3-4.70
Paola Rocchi, Roberto Tonelli, Consuelo Camerin, Stefania Purgato, Raffaele Fronza, Fabrizio Bianucci, Francesco Guerra, Andrea Pession, Anna Ferreri, p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Oncology Reports. ,vol. 13, pp. 1139- 1144 ,(2005) , 10.3892/OR.13.6.1139
Yu Zhang, Na Li, Cécile Caron, Gabriele Matthias, Daniel Hess, Saadi Khochbin, Patrick Matthias, HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo The EMBO Journal. ,vol. 22, pp. 1168- 1179 ,(2003) , 10.1093/EMBOJ/CDG115
Jeffrey J. Kovacs, Patrick J.M. Murphy, Stéphanie Gaillard, Xuan Zhao, June-Tai Wu, Christopher V. Nicchitta, Minoru Yoshida, David O. Toft, William B. Pratt, Tso-Pang Yao, HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor Molecular Cell. ,vol. 18, pp. 601- 607 ,(2005) , 10.1016/J.MOLCEL.2005.04.021